- Home
- XERS vs ATUS Comparison
XERS vs ATUS Comparison
Compare XERS & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- ATUS
- Stock Information
- Founded
- XERS 2005
- ATUS 2015
- Country
- XERS United States
- ATUS United States
- Employees
- XERS N/A
- ATUS N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- ATUS Cable & Other Pay Television Services
- Sector
- XERS Health Care
- ATUS Telecommunications
- Exchange
- XERS Nasdaq
- ATUS Nasdaq
- Market Cap
- XERS 1.3B
- ATUS 1.0B
- IPO Year
- XERS 2018
- ATUS 2017
- Fundamental
- Price
- XERS $7.64
- ATUS $1.96
- Analyst Decision
- XERS Strong Buy
- ATUS Hold
- Analyst Count
- XERS 7
- ATUS 5
- Target Price
- XERS $9.43
- ATUS $2.55
- AVG Volume (30 Days)
- XERS 3.0M
- ATUS 3.8M
- Earning Date
- XERS 11-06-2025
- ATUS 11-06-2025
- Dividend Yield
- XERS N/A
- ATUS N/A
- EPS Growth
- XERS N/A
- ATUS N/A
- EPS
- XERS N/A
- ATUS N/A
- Revenue
- XERS $266,137,000.00
- ATUS $8,642,622,000.00
- Revenue This Year
- XERS $43.89
- ATUS N/A
- Revenue Next Year
- XERS $20.40
- ATUS N/A
- P/E Ratio
- XERS N/A
- ATUS N/A
- Revenue Growth
- XERS 42.05
- ATUS N/A
- 52 Week Low
- XERS $2.82
- ATUS $1.88
- 52 Week High
- XERS $10.08
- ATUS $3.20
- Technical
- Relative Strength Index (RSI)
- XERS 36.31
- ATUS 31.09
- Support Level
- XERS $7.00
- ATUS $1.88
- Resistance Level
- XERS $10.08
- ATUS $2.19
- Average True Range (ATR)
- XERS 0.53
- ATUS 0.13
- MACD
- XERS -0.26
- ATUS -0.02
- Stochastic Oscillator
- XERS 23.38
- ATUS 9.09
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.